Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

CT and MRI Features of Chondrosarcoma in the Mastoid Involving the Facial Nerve in Comparison to Facial Nerve Schwannoma

Author(s): Jun-hua Liu, Meng Qi, Yan Sha and Fang Zhang*

Volume 20, 2024

Published on: 14 April, 2023

Article ID: e280323215030 Pages: 8

DOI: 10.2174/1573405620666230328090514

open_access

Abstract

Background: Chondrosarcoma in the mastoid is extremely rare, and it is easily misdiagnosed as a facial nerve schwannoma.

Objective: To identify and compare computed tomography (CT) and magnetic resonance imaging (MRI) features of chondrosarcoma in the mastoid involving the facial nerve, including diffusion-weighted MRI characteristics, with those of facial nerve schwannoma.

Methods: CT and MRI features of 11 chondrosarcomas in the mastoid involving the facial nerve and 15 facial nerve schwannomas, confirmed by histopathology, were retrospectively reviewed. The tumor location, size, morphological features, bone change, calcification, signal intensity, texture, enhancement characteristics, the extent of lesions, and apparent diffusion coefficients (ADCs) were evaluated.

Results: On CT imaging, calcification could be found in 81.8% of chondrosarcomas (9/11) and 33.3% of facial nerve schwannomas (5/15). Chondrosarcoma in the mastoid appeared significantly hyperintense on T2-weighted images (T2WI) with low signal intensity septa in eight patients (72.7%, 8/11). After contrast, all chondrosarcomas showed inhomogeneous enhancement, and septal and peripheral enhancement could be found in six cases (54.5%, 6/11). Facial nerve schwannoma demonstrated inhomogeneous hyperintensity on T2WI in 12 cases (80%, 12/15), with obvious hyperintense cystic changes in seven cases. There were significant differences in calcification (P=0.014), T2 signal intensity (P=0.006), and septal and peripheral enhancement (P=0.001) between chondrosarcomas and facial nerve schwannomas. The ADCs of chondrosarcoma were significantly higher than those of facial nerve schwannomas (P<0.001).

Conclusion: CT and MRI with ADCs had the potential to improve the diagnostic accuracy of chondrosarcoma in the mastoid involving the facial nerve.

Keywords: Chondrosarcoma, Mastoid, Computed tomography, Magnetic resonance imaging, Diffusion-weighted imaging, Facial nerve schwannoma.

[1]
Ellis MA, Gerry DR, Byrd JK. Head and neck chondrosarcomas: Analysis of the surveillance, epidemiology, and end results database. Head Neck 2016; 38(9): 1359-66.
[http://dx.doi.org/10.1002/hed.24434] [PMID: 27042949]
[2]
Koch BB, Karnell LH, Hoffman HT, et al. National cancer database report on chondrosarcoma of the head and neck. Head Neck 2000; 22(4): 408-25.
[http://dx.doi.org/10.1002/1097-0347(200007)22:4<408::AID-HED15>3.0.CO;2-H] [PMID: 10862026]
[3]
Hong P, Taylor SM, Trites JR, Bullock M, Nasser JG, Hart RD. Chondrosarcoma of the head and neck: Report of 11 cases and literature review. J Otolaryngol Head Neck Surg 2009; 38(2): 279-85.
[PMID: 19442379]
[4]
Coca-Pelaz A, Rodrigo JP, Triantafyllou A, et al. Chondrosarcomas of the head and neck. Eur Arch Otorhinolaryngol 2014; 271(10): 2601-9.
[PMID: 24213203]
[5]
Lee SY, Lim YC, Song MH, Seok JY, Lee WS, Choi EC. Chondrosarcoma of the head and neck. Yonsei Med J 2005; 46(2): 228-32.
[http://dx.doi.org/10.3349/ymj.2005.46.2.228] [PMID: 15861495]
[6]
Van Gompel JJ, Janus JR. Chordoma and chondrosarcoma. Otolaryngol Clin North Am 2015; 48(3): 501-14.
[http://dx.doi.org/10.1016/j.otc.2015.02.009] [PMID: 25863568]
[7]
Tao D, Hoffman MR, Chen B. Temporal bone chondrosarcoma: Presentation of 4 cases and review of the literature. Ear Nose Throat J 2014; 93(12): 494-500.
[PMID: 25531842]
[8]
Lustig LR, Sciubba J, Holliday MJ. Chondrosarcomas of the skull base and temporal bone. J Laryngol Otol 2007; 121(8): 725-35.
[http://dx.doi.org/10.1017/S0022215107006081] [PMID: 17319989]
[9]
Frisch CD, Inwards CY, Lalich IJ, Carter JM, Neff BA. Atypical cartilaginous tumor/chondrosarcoma, grade 1, of the mastoid in three family members: A new entity. Laryngoscope 2016; 126(9): E310-3.
[http://dx.doi.org/10.1002/lary.25802] [PMID: 26667047]
[10]
Zhao EE, Liu YF, Oyer SL, Smith MT, McRackan TR. Chondrosarcoma arising in the mastoid involving the intratemporal facial nerve. JAMA Otolaryngol Head Neck Surg 2019; 145(4): 392-3.
[http://dx.doi.org/10.1001/jamaoto.2018.4149] [PMID: 30816921]
[11]
Driessen JP, van Kempen PMW, van der Heijden GJ, et al. Diffusion-weighted imaging in head and neck squamous cell carcinomas: A systematic review. Head Neck 2015; 37(3): 440-8.
[http://dx.doi.org/10.1002/hed.23575] [PMID: 24347513]
[12]
Ginat DT. MR imaging of nasal and paranasal sinus malignant neoplasms. Magn Reson Imaging Clin N Am 2022; 30(1): 73-80.
[http://dx.doi.org/10.1016/j.mric.2021.07.003] [PMID: 34802582]
[13]
Imhof H, Henk CB, Dirisamer A, Czerny C, Gstöttner W. [CT and MRI characteristics of tumours of the temporal bone and the cerebello-pontine angle]. Radiologe 2003; 43(3): 219-26.
[http://dx.doi.org/10.1007/s00117-003-0870-2] [PMID: 12664237]
[14]
Wangaryattawanich P, Agarwal M, Rath T. Imaging features of cartilaginous tumors of the head and neck. J Clin Imaging Sci 2021; 11: 66.
[http://dx.doi.org/10.25259/JCIS_186_2021] [PMID: 34992942]
[15]
Baba A, Kurokawa R, Kurokawa M, Ota Y, Lobo R, Srinivasan A. Imaging features of laryngeal chondrosarcomas: A case series and systematic review. J Neuroimaging 2022; 32(2): 213-22.
[http://dx.doi.org/10.1111/jon.12963] [PMID: 35019171]
[16]
Fan X, Liu Z, Ding C, Chang Z, Ma Q. The value of turbo spin-echo diffusion-weighted imaging apparent diffusion coefficient in the diagnosis of temporal bone cholesteatoma. Clin Radiol 2019; 74(12): 977.e1-7.
[http://dx.doi.org/10.1016/j.crad.2019.08.016] [PMID: 31563292]
[17]
Okada K, Ito K, Yamasoba T, Ishii M, Iwasaki S, Kaga K. Benign mass lesions deep inside the temporal bone: Imaging diagnosis for proper management. Acta Otolaryngol 2007; 127(sup559): 71-7.
[http://dx.doi.org/10.1080/03655230701597127] [PMID: 18340574]
[18]
Zuo W, Wang F, Yang S, et al. Clinical characteristics of petrosal cholesteatoma and value of MRI-DWI in the diagnosis. Acta Otolaryngol 2020; 140(4): 281-5.
[http://dx.doi.org/10.1080/00016489.2019.1701707] [PMID: 31876216]
[19]
Yagisawa M, Ishitoya J, Tsukuda M, Sakagami M. Chondrosarcoma of the temporal bone. Auris Nasus Larynx 2007; 34(4): 527-31.
[http://dx.doi.org/10.1016/j.anl.2007.03.009] [PMID: 17490837]
[20]
Raghu M, Moumoulidis I, De R, Moffat D. Chondrosarcomas of the temporal bone: Presentation and management. J Laryngol Otol 2004; 118(7): 551-5.
[http://dx.doi.org/10.1258/0022215041615272] [PMID: 15318964]
[21]
Carlson ML, O’Connell BP, Breen JT, et al. Petroclival chondrosarcoma. Otol Neurotol 2016; 37(7): 940-50.
[http://dx.doi.org/10.1097/MAO.0000000000001037] [PMID: 27273403]
[22]
Zhang K, Qu P, Zhang E, Dai C, Shu Y, Chen B. Primary temporal bone chondrosarcoma: Experience with 10 cases. Acta Otolaryngol 2019; 139(10): 837-42.
[http://dx.doi.org/10.1080/00016489.2019.1641220] [PMID: 31373256]
[23]
Awad M, Gogos AJ, Kaye AH. Skull base chondrosarcoma. J Clin Neurosci 2016; 24: 1-5.
[http://dx.doi.org/10.1016/j.jocn.2015.10.029] [PMID: 26724847]
[24]
Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP. Radiographics 2003; 23(5): 1245-78.
[http://dx.doi.org/10.1148/rg.235035134] [PMID: 12975513]
[25]
Fukuda A, de Castro ODL, Fernandes JA, Amstalden EMI, de Souza QL, Reis F. Vertebral body chondrosarcoma with metastasis to the scalp. BJR Case Rep 2019; 5(1): 20180037.
[http://dx.doi.org/10.1259/bjrcr.20180037] [PMID: 31131120]
[26]
Kremenevski N, Schlaffer SM, Coras R, Kinfe TM, Graillon T, Buchfelder M. Skull base chordomas and chondrosarcomas. Neuroendocrinology 2020; 110(9-10): 836-47.
[http://dx.doi.org/10.1159/000509386] [PMID: 32541136]
[27]
De Beuckeleer LHL, De Schepper AMA, Ramon F, Somville J. Magnetic resonance imaging of cartilaginous tumors: A retrospective study of 79 patients. Eur J Radiol 1995; 21(1): 34-40.
[http://dx.doi.org/10.1016/0720-048X(96)81067-9] [PMID: 8654456]
[28]
Geirnaerdt MJ, Bloem JL, Eulderink F, Hogendoorn PC, Taminiau AH. Cartilaginous tumors: Correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology 1993; 186(3): 813-7.
[http://dx.doi.org/10.1148/radiology.186.3.8430192] [PMID: 8430192]
[29]
Soldatos T, McCarthy EF, Attar S, Carrino JA, Fayad LM. Imaging features of chondrosarcoma. J Comput Assist Tomogr 2011; 35(4): 504-11.
[http://dx.doi.org/10.1097/RCT.0b013e31822048ff] [PMID: 21765311]
[30]
Dalaqua M, Nascimento FBP, Miura LK, Garcia MRT, Barbosa Junior AA, Reis F. Magnetic resonance imaging of the cranial nerves in infectious, neoplastic, and demyelinating diseases, as well as other inflammatory diseases: A pictorial essay. Radiol Bras 2022; 55(1): 38-46.
[http://dx.doi.org/10.1590/0100-3984.2021.0042] [PMID: 35210663]
[31]
Wippold FJ II, Lubner M, Perrin RJ, Lämmle M, Perry A. Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns. AJNR Am J Neuroradiol 2007; 28(9): 1633-8.
[http://dx.doi.org/10.3174/ajnr.A0682] [PMID: 17893219]
[32]
Lahlou G, Nguyen Y, Russo FY, Ferrary E, Sterkers O, Bernardeschi D. Intratemporal facial nerve schwannoma: Clinical presentation and management. Eur Arch Otorhinolaryngol 2016; 273(11): 3497-504.
[http://dx.doi.org/10.1007/s00405-015-3850-z] [PMID: 26676873]
[33]
Hayashida Y, Hirai T, Yakushiji T, et al. Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses: Initial experience. J Magn Reson Imaging 2006; 23(3): 377-82.
[http://dx.doi.org/10.1002/jmri.20512] [PMID: 16475145]
[34]
Yakushiji T, Oka K, Sato H, et al. Characterization of chondroblastic osteosarcoma: Gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging 2009; 29(4): 895-900.
[http://dx.doi.org/10.1002/jmri.21703] [PMID: 19306430]
[35]
Müller U, Kubik-Huch RA, Ares C, et al. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma? Acta Radiol 2016; 57(2): 225-32.
[http://dx.doi.org/10.1177/0284185115574156] [PMID: 25722460]

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy